Convertible issuance was exceptionally robust over the quarter, and we expect a favorable issuance environment to continue.

NeuroKaire, a pioneer in precision psychiatry and neurology, has launched an R&D collaboration with Compass Pathways, a leading biotechnology company dedicated to transforming mental health care.

A $100 million superyacht blending into the crowd? Only in Fort Lauderdale. The 66th Annual Fort Lauderdale International ...

Iris Ventures, the global investment firm behind some of beauty and wellness's most trailblazing and transformative brands, has made a multimillion-dollar minority investment in Goddess Maintenance Co ...

Most high hits are the result of nervous, string-jumping whitetails and steep shot angles taken from a high treestand. So, ...

Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...

Optimizing the aging process isn’t a new concept for researchers. Scientists have long studied the world’s Blue Zones ...

Among them, Lucentis® is the first anti-vascular endothelial growth factor (VEGF) drug approved for ophthalmic use in China, and has accumulated mature clinical application experience, providing ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

JAECOO Philippines is serious about pushing the boundaries of the local SUV market. During the recently concluded global brand conference in Wuhu, China, the Philippine media contingent was among the ...